First, the effect of inhibiting CRM1 with LMB, a canonical CRM1 inhibitor (31, –, 33), on DHOV replication was investigated in the permissive cell line human hepatoma Huh7 (34). Here, XPO1 is linked to hepatocellular carcinoma.